ライフサイエンスコーパス: cystoid macular edema

1 g anterior chamber reactions, and inhibiting cystoid macular edema.

2 33% of patients developed cystoid macular edema.

3 pensation, glaucoma, retinal detachment, and cystoid macular edema.

4 thickness in RP patients with no history of cystoid macular edema.

5 with MME, while 93 (29.2%) showed "typical" cystoid macular edema.

6 eyes experienced more frequent postoperative cystoid macular edema.

7 lmitis, or intermediate/posterior uveitis or cystoid macular edema.

8 d thickness (CST) over time, and presence of cystoid macular edema.

9 al contour, in some cases "stage 0" ROP, and cystoid macular edema.

10 omplication recorded after PPV was a case of cystoid macular edema.

11 ghteen of the 61 eyes (29.5%) also developed cystoid macular edema.

12 xime as measured by the incidence of POE and cystoid macular edema.

13 ar degeneration, vitreomacular traction, and cystoid macular edema.

14 xel may cause ocular adverse effects such as cystoid macular edema.

15 n the central macula with or without typical cystoid macular edema.

16 1 day of treatment, and 1 patient developed cystoid macular edema.

17 ery-associated retinal complications such as cystoid macular edema.

18 s whether NSAIDS can reduce the incidence of cystoid macular edema.

19 ement of both postoperative inflammation and cystoid macular edema.

20 lar hole, diabetic retinopathy, uveitis, and cystoid macular edema.

21 can lead to retinal disease de novo, such as cystoid macular edema.

22 seudotumor cerebri, thyroid orbitopathy, and cystoid macular edema.

23 eitis-glaucoma-hyphema syndrome, and chronic cystoid macular edema.

24 ases, suboptimal visual results secondary to cystoid macular edema.

25 al anterior synechiae, or known or suspected cystoid macular edema.

26 Postoperative complications included cystoid macular edema (10%), corneal decompensation (6%)

27 cation (50.9%), posterior synechiae (21.7%), cystoid macular edema (16%), epiretinal membrane (13.2%)

28 [4%]), retained cortical fragment (1 [4%]), cystoid macular edema (2 [8%]), and IOL subluxation (3 [

29 ction (4%), corneal decompensation (2%), and cystoid macular edema (2%).

30 glaucoma (4.7%), retinal detachment (4.1%), cystoid macular edema (2.1%), and uveitis (1%) were foun

31 ar hypertension (29 eyes, 10%) and transient cystoid macular edema (25 eyes, 8.6%).

32 The most prevalent change was cystoid macular edema [28 eyes, (17.4%)], followed by ep

33 ve complications occurred in 5.2%, primarily cystoid macular edema (3.7%).

34 lar thickening (95.3% vs. 51.6%, p < 0.001), cystoid macular edema (36% vs. 11.7%, p < 0.001), subret

35 (11 eyes), iris neovascularization (2 eyes), cystoid macular edema (4 eyes), and hyphema (1 eye).

36 hypertension (12.9%), corneal edema (8.9%), cystoid macular edema (6.9%), and vitreous hemorrhage (5

37 l neovascularization (5%), atrophy (5%), and cystoid macular edema (9%).

38 m was associated with a higher prevalence of cystoid macular edema, active uveitis, and optic disc sw

39 Cystoid macular edema after cataract surgery has a tende

40 st 1, 2001 and July 31, 2002 on the topic of cystoid macular edema after cataract surgery.

41 um occurred in 100% (15/15); 2) reduction in cystoid macular edema and improvement of outer retinal c

42 valuable for detecting complications such as cystoid macular edema and retinal thinning.

43 Cystoid macular edema and vitreous hyperreflective foci

44 Twenty-seven eyes had cystoid macular edema, and 10 eyes had diffuse macular e

45 f vision loss, including retinal detachment, cystoid macular edema, and optic neuropathy.

46 corneal edema, intraocular pressure spikes, cystoid macular edema, and posterior capsule opacificati

47 Rates of immune recovery uveitis, new-onset cystoid macular edema, and retinal detachment were 0%, 1

48 topathy, trace to 2+ anterior chamber cells, cystoid macular edema, and retinal vasculitis on fluores

49 ised sponge-like diffuse retinal thickening, cystoid macular edema, and serous retinal detachment.

50 ch may include pseudocysts, macular schisis, cystoid macular edema, and subretinal fluid.

51 lvement; intraocular inflammation, including cystoid macular edema; and retinal degeneration.

52 Forty-four eyes had cystoid macular edema at baseline (55%), and 41 eyes (51

53 Eighteen eyes exhibited cystoid macular edema at baseline (56%), and 17 eyes (53

54 OCT showed cystoid macular edema at presentation in 3 patients, whi

55 oherence tomography macula showed parafoveal cystoid macular edema bilaterally.

56 eyes and seven eyes with retinal pathology (cystoid macular edema, central serous retinopathy, vitre

57 d with higher rates of complications such as cystoid macular edema (CME) (15% vs. 4%, P < .001), need

58 These included cystoid macular edema (CME) (172 eyes; 0.496%), signific

59 complications were uveal effusion (9.3%) and cystoid macular edema (CME) (7.0%).

60 evaluate the incidence and risk factors for cystoid macular edema (CME) and epiretinal membrane (ERM

61 total images were acquired and evaluated for cystoid macular edema (CME) and persistence of inner ret

62 ibizumab-treated CRVO patients with resolved cystoid macular edema (CME) at month 3, those with persi

63 Cystoid macular edema (CME) before intraocular surgery w

64 s pigmentosa; 37 (21%) of these patients had cystoid macular edema (CME) by OCT.

65 Postoperative cystoid macular edema (CME) developed in 45 eyes (9.6%),

66 Published reports of the occurrence of cystoid macular edema (CME) in eyes being treated with l

67 IDs) are effective in decreasing the risk of cystoid macular edema (CME) in high-risk eyes, but must

68 Cystoid macular edema (CME) in retinitis pigmentosa (RP)

69 Current treatments for cystoid macular edema (CME) in retinitis pigmentosa (RP)

70 However, the risk of postoperative cystoid macular edema (CME) in RP remains unclear.

71 mor thickness (2.9 mm vs. 3.2 mm; P = 0.01), cystoid macular edema (CME) involving the foveola (30% v

72 Cystoid macular edema (CME) is a common problem after ca

73 Cystoid macular edema (CME) is a leading cause of blindn

74 Cystoid macular edema (CME) occurred in 5 eyes (0.87%):

75 ld, with a vitreous haze score of >/=1.5+ or cystoid macular edema (CME) of >300 mum were enrolled.

76 ) in cataract surgery with specific focus on cystoid macular edema (CME) on the basis of expert opini

77 OP), corneal edema, iritis, IOL dislocation, cystoid macular edema (CME) or endophthalmitis, were rep

78 None of patients developed cystoid macular edema (CME) or macular epiretinal membra

79 ral retinal thickness was similar (P = .97); cystoid macular edema (CME) was found in 4 and 5 patient

80 Epiretinal membrane (ERM) and cystoid macular edema (CME) were graded after surgery.

81 sual acuity, intraocular pressure (IOP), and cystoid macular edema (CME) were recorded at each visit.

82 Rates of epiretinal membrane (ERM) and cystoid macular edema (CME) were significantly lower in

83 al acuity (VA), complications, resolution of cystoid macular edema (CME), and anterior chamber and vi

84 inal hard exudates, retinal detachment (RD), cystoid macular edema (CME), and epiretinal membrane (ER

85 ion rates including retinal detachment (RD), cystoid macular edema (CME), and epiretinal membrane for

86 ourse can be complicated by inflammation and cystoid macular edema (CME), and in uveitic patients, in

87 in retinal dystrophy, differentiate it from cystoid macular edema (CME), and review the role of carb

88 mation, best corrected visual acuity (BCVA), cystoid macular edema (CME), and the highest fluorescein

89 lary leakage in 36.4% of eyes without MME or cystoid macular edema (CME), in 39% of eyes with MME, an

90 ntour, persistent fetal foveal architecture, cystoid macular edema (CME), intraretinal exudates and s

91 ase, vitreous opacities, retinal detachment, cystoid macular edema (CME), macular scarring, macular h

92 First diagnosis of (1) epiphora, (2) cystoid macular edema (CME), or (3) optic neuropathy asc

93 uthors retrospectively selected visits where cystoid macular edema (CME), subretinal fluid (SRF), or

94 lar traction, epiretinal membrane (ERM), and cystoid macular edema (CME), were analyzed.

95 pose patients with glaucoma to develop acute cystoid macular edema (CME).

96 with visual acuity (VA) in eyes with uveitic cystoid macular edema (CME).

97 ntraocular pressure (IOP) increase (n = 12), cystoid macular edema (CME; n = 3), and nonarteritic ant

98 choroidal hemorrhage, infectious keratitis, cystoid macular edema [CME], retinal detachment [RD], or

99 In the parous group, 21% had cystoid macular edema (CMO) requiring treatment and 46%

100 Study [ETDRS] of 55 letters or better); (2) cystoid macular edema (CMO), foveal thickness, and macul

101 risk of outer retinal band discontinuity and cystoid macular edema compared with PRB or PR.

102 The rate of cystoid macular edema decreased from 22.7% at baseline t

103 Postoperative cystoid macular edema developed in 6.9% of RP eyes and 1

104 Cystoid macular edema did not occur as a postoperative c

105 result in different complications including cystoid macular edema, endophthalmitis, glaucoma, and co

106 multiple processes, including postoperative cystoid macular edema, epiretinal membrane formation, ma

107 Anterior uveitis, cataract, vitritis, cystoid macular edema, epiretinal membrane, and disc ede

108 done for all eyes assessing the presence of cystoid macular edema, epiretinal membrane, macular hole

109 ave been shown to be effective in preventing cystoid macular edema following cataract surgery or trea

110 nd perimeter in ICP and DCP, and presence of cystoid macular edema, HE, and cataract were higher in e

111 idence interval {CI}, 2.15-4.35], P < .001), cystoid macular edema (HR = 2.87 [95% CI, 1.41-5.82], P

112 Other complications included cystoid macular edema in 1 eye (2.4%), posterior synechi

113 re a transient IOP spike in 8 (17%) eyes and cystoid macular edema in 6 eyes (13%).

114 OCT on presentation demonstrated cystoid macular edema in 8 of 20 eyes and symptomatic vi

115 t underlying pathophysiologic foundation for cystoid macular edema in retinal vascular diseases.

116 Cystoid macular edema in retinal vein occlusion occurred

117 form changes that were hyperautofluorescent, cystoid macular edema in the inner nuclear layer, no lig

118 Four eyes (12%) had cystoid macular edema in the repositioning group compare

119 Pseudophakic cystoid macular edema is an important cause of visual de

120 Pseudophakic cystoid macular edema is common after phacoemulsificatio

121 Usually vision loss from cystoid macular edema is temporary and responds to treat

122 Cystoid macular edema may be more likely to develop in p

123 1), retinal neovascularization (n = 1), and cystoid macular edema (n = 1).

124 dialysis (n = 15; 5%) and (exacerbation of) cystoid macular edema (n = 14; 5%), respectively.

125 = 65; 29.4%), cataract (n = 41; 18.5%), and cystoid macular edema (n = 29; 13.1%).

126 rradiation and intravitreal therapy to treat cystoid macular edema not originating from the optic dis

127 Cystoid macular edema observed on SD OCT in very preterm

128 nd optical coherence tomography (OCT) showed cystoid macular edema on both eyes.

129 edema following cataract surgery or treating cystoid macular edema once it occurs.

130 subclinical susceptibility to postoperative cystoid macular edema or exacerbation of choroidal neova

131 Diagnosis of cystoid macular edema or new-onset macular edema in pati

132 less commonly associated with postoperative cystoid macular edema (OR = 0.36, 95% CI: 0.14-0.91, P =

133 ewed OCT scans to determine the type of DME, cystoid macular edema, or diffuse macular edema (absence

134 y related to visual acuity, age, presence of cystoid macular edema, or subjects' stress or anxiety le

135 lar edema (DME) or postvitrectomy persistent cystoid macular edema (P < .05).

136 no differences between groups when assessing cystoid macular edema (P = .96), retinal detachment (P =

137 AR of BCVA was associated significantly with cystoid macular edema (p = 0.001), ellipsoid zone(p = 0.

138 (2) = 48%; n = 4 studies, 321 participants), cystoid macular edema (P = 0.15; I(2) = 0%; n = 6 studie

139 (P = 0.15), retinal detachments (P = 0.76), cystoid macular edema (P = 0.83), or timing of complicat

140 s with dark irides had a higher incidence of cystoid macular edema, PCE, and rebound inflammation in

141 on between serum biomarkers and pseudophakic cystoid macular edema (PCME) in eyes without risk factor

142 Pseudophakic cystoid macular edema (PCME) is a common cause of visual

143 ification for the prevention of pseudophakic cystoid macular edema (PCME) using a prospective, random

144 At 28 days postsurgery, pseudophakic cystoid macular edema (PCME) was reported in 8 eyes, of

145 afenac 0.3% in the treatment of pseudophakic cystoid macular edema (PCME).

146 Cystoid macular edema persisted in 9 of 11 eyes affected

147 ation between drainage technique and risk of cystoid macular edema (PRB 28%, PR 39%, PFCL 46%, P = .0

148 Older subjects were more likely to develop cystoid macular edema, raised intraocular pressure and c

149 Cystoid macular edema refractory to carbonic anhydrase i

150 , any occurrence of immune recovery uveitis, cystoid macular edema, retinal detachment, or a combinat

151 ressure control, worsening of visual acuity, cystoid macular edema, retroprosthetic membrane formatio

152 s, dry age-related macular degeneration, and cystoid macular edema (ROR 445, 95% CI 140-1412).

153 Cystoid macular edema seems to be a marker for poorer vi

154 Cystoid macular edema was common in those with preserved

155 The risk for the development of cystoid macular edema was found to be associated with re

156 ly [P = .001]), whereas an increased risk of cystoid macular edema was not identified for those who r

157 In one eye, development of cystoid macular edema was observed before the outer reti

158 No cystoid macular edema was observed in the control group.

159 Cystoid macular edema was present in 9, 1, 5, 9, and 1 p

160 Cystoid macular edema was seen in 25 of the 46 patients

161 as assessed by multiadjusted odds of retinal cystoid macular edema, was not increased for patients re

162 Compared with ACIOL, complications of cystoid macular edema were higher in 10-0 polypropylene

163 r chamber and vitreous cell, and presence of cystoid macular edema were obtained from the medical cha

164 rneal edema (PCE), rebound inflammation, and cystoid macular edema, were compared between the 2 group

165 Cystoid macular edema, which was present in 40 eyes at b

166 20/13 to 20/40(+2), except in 1 patient with cystoid macular edema whose vision was 20/60(-) and 20/7

167 vascular plexus were analyzed in relation to cystoid macular edema with retention of depth informatio

168 acy (for both postoperative inflammation and cystoid macular edema) without the typically corticoster